Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2015 Feb 27;2909:5241-55. doi: 10.1074/jbc.M114.623496.
Show Gene links
Show Anatomy links
Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.
Ji HL, Zhao R, Komissarov AA, Chang Y, Liu Y, Matthay MA.
???displayArticle.abstract??? Plasminogen activator inhibitor 1 (PAI-1) level is extremely elevated in the edematous fluid of acutely injured lungs and pleurae. Elevated PAI-1 specifically inactivates pulmonary urokinase-type (uPA) and tissue-type plasminogen activators (tPA). We hypothesized that plasminogen activation and fibrinolysis may alter epithelial sodium channel (ENaC) activity, a key player in clearing edematous fluid. Two-chain urokinase (tcuPA) has been found to strongly stimulate heterologous human αβγ ENaC activity in a dose- and time-dependent manner. This activity of tcuPA was completely ablated by PAI-1. Furthermore, a mutation (S195A) of the active site of the enzyme also prevented ENaC activation. By comparison, three truncation mutants of the amino-terminal fragment of tcuPA still activated ENaC. uPA enzymatic activity was positively correlated with ENaC current amplitude prior to reaching the maximal level. In sharp contrast to uPA, neither single-chain tPA nor derivatives, including two-chain tPA and tenecteplase, affected ENaC activity. Furthermore, γ but not α subunit of ENaC was proteolytically cleaved at ((177)GR↓KR(180)) by tcuPA. In summary, the underlying mechanisms of urokinase-mediated activation of ENaC include release of self-inhibition, proteolysis of γ ENaC, incremental increase in opening rate, and activation of closed (electrically "silent") channels. This study for the first time demonstrates multifaceted mechanisms for uPA-mediated up-regulation of ENaC, which form the cellular and molecular rationale for the beneficial effects of urokinase in mitigating mortal pulmonary edema and pleural effusions.
Bertozzi,
Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome.
1990, Pubmed
Bertozzi,
Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome.
1990,
Pubmed Bhattacharya,
Regulation and repair of the alveolar-capillary barrier in acute lung injury.
2013,
Pubmed Bouros,
Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema.
1996,
Pubmed Caldwell,
Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport.
2005,
Pubmed Caldwell,
Serine protease activation of near-silent epithelial Na+ channels.
2004,
Pubmed Chapman,
Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.
1986,
Pubmed Chen,
Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency.
2014,
Pubmed
,
Xenbase Chen,
Influenza virus inhibits ENaC and lung fluid clearance.
2004,
Pubmed Chraïbi,
Na self inhibition of human epithelial Na channel: temperature dependence and effect of extracellular proteases.
2002,
Pubmed
,
Xenbase Coombs,
Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen activator.
1998,
Pubmed Crippa,
Urokinase-type plasminogen activator.
2007,
Pubmed Dagenais,
Modulation of epithelial sodium channel (ENaC) expression in mouse lung infected with Pseudomonas aeruginosa.
2005,
Pubmed Davis,
Epithelial sodium channels in the adult lung--important modulators of pulmonary health and disease.
2007,
Pubmed Diakov,
Cleavage in the {gamma}-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels.
2008,
Pubmed
,
Xenbase Ding,
Origins of the specificity of tissue-type plasminogen activator.
1995,
Pubmed Eaton,
The contribution of epithelial sodium channels to alveolar function in health and disease.
2009,
Pubmed Fuller,
Kinetic interconversion of rat and bovine homologs of the alpha subunit of an amiloride-sensitive Na+ channel by C-terminal truncation of the bovine subunit.
1996,
Pubmed
,
Xenbase García-Caballero,
ENaC proteolytic regulation by channel-activating protease 2.
2008,
Pubmed Glas,
Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.
2013,
Pubmed Goldfarb,
Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels.
2006,
Pubmed
,
Xenbase Gonzales,
Pore architecture and ion sites in acid-sensing ion channels and P2X receptors.
2009,
Pubmed Gross,
Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells.
1990,
Pubmed Günther,
Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
2003,
Pubmed Haerteis,
Plasmin and chymotrypsin have distinct preferences for channel activating cleavage sites in the γ subunit of the human epithelial sodium channel.
2012,
Pubmed
,
Xenbase Haerteis,
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
2009,
Pubmed
,
Xenbase Hochberg,
Patterns of alveolar fluid clearance in heart failure.
2008,
Pubmed Huang,
Tissue plasminogen activator attenuates ventilator-induced lung injury in rats.
2012,
Pubmed Hummler,
Importance of ENaC-mediated sodium transport in alveolar fluid clearance using genetically-engineered mice.
2010,
Pubmed Idell,
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
1989,
Pubmed Idell,
The pathogenesis of pleural space loculation and fibrosis.
2008,
Pubmed Idell,
Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury.
1992,
Pubmed Idell,
Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
1992,
Pubmed Idell,
Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
2007,
Pubmed Idell,
Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome.
1991,
Pubmed Idell,
Abnormalities of pathways of fibrin turnover in the human pleural space.
1991,
Pubmed Idell,
Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
2007,
Pubmed Jasti,
Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH.
2007,
Pubmed Ji,
Point mutations in the post-M2 region of human alpha-ENaC regulate cation selectivity.
2001,
Pubmed
,
Xenbase Ji,
Degenerin sites mediate proton activation of deltabetagamma-epithelial sodium channel.
2004,
Pubmed
,
Xenbase Ji,
δ ENaC: a novel divergent amiloride-inhibitable sodium channel.
2012,
Pubmed Ji,
Peptide inhibition of constitutively activated epithelial Na(+) channels expressed in Xenopus oocytes.
1999,
Pubmed
,
Xenbase Ji,
Delta-subunit confers novel biophysical features to alpha beta gamma-human epithelial sodium channel (ENaC) via a physical interaction.
2006,
Pubmed Ke,
Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase.
1997,
Pubmed Ke,
Optimal subsite occupancy and design of a selective inhibitor of urokinase.
1997,
Pubmed Kleyman,
ENaC at the cutting edge: regulation of epithelial sodium channels by proteases.
2009,
Pubmed Knight,
Intracellular sodium regulates proteolytic activation of the epithelial sodium channel.
2008,
Pubmed Komissarov,
Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
2013,
Pubmed Komissarov,
Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
2009,
Pubmed Kotani,
Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
1995,
Pubmed Kunzelmann,
Influenza virus inhibits amiloride-sensitive Na+ channels in respiratory epithelia.
2000,
Pubmed Kuramoto,
Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model.
2009,
Pubmed Kvassman,
The acid stabilization of plasminogen activator inhibitor-1 depends on protonation of a single group that affects loop insertion into beta-sheet A.
1995,
Pubmed Lee,
Treatment of thoracic multiloculated empyemas with intracavitary urokinase: a prospective study.
1991,
Pubmed MacLaren,
Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults.
2002,
Pubmed Madison,
Substrate specificity of tissue type plasminogen activator. Characterization of the fibrin independent specificity of t-PA for plasminogen.
1995,
Pubmed Maron,
Beta-adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failure.
2009,
Pubmed Marshall,
Alveolar epithelial cell plasminogen activator. Characterization and regulation.
1990,
Pubmed Matthay,
Lung epithelial fluid transport and the resolution of pulmonary edema.
2002,
Pubmed Matthay,
Resolution of pulmonary edema. Thirty years of progress.
2014,
Pubmed Miyake,
Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer.
1999,
Pubmed Molina,
Cpt-cAMP activates human epithelial sodium channels via relieving self-inhibition.
2011,
Pubmed
,
Xenbase Münster,
Jet and ultrasonic nebulization of single chain urokinase plasminogen activator (scu-PA).
2000,
Pubmed Nishiuma,
Localization of plasminogen activator activity within normal and injured lungs by in situ zymography.
2004,
Pubmed Passero,
Plasmin activates epithelial Na+ channels by cleaving the gamma subunit.
2008,
Pubmed
,
Xenbase Pechlaner,
Plasminogen activators in inflammation and sepsis.
2002,
Pubmed Planès,
Regulation of the epithelial Na+ channel by peptidases.
2007,
Pubmed
,
Xenbase Prabhakaran,
Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.
2003,
Pubmed Renckens,
Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia.
2008,
Pubmed Rossier,
Activation of the epithelial sodium channel (ENaC) by serine proteases.
2009,
Pubmed Rossier,
The epithelial sodium channel: activation by membrane-bound serine proteases.
2004,
Pubmed Sapru,
Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury.
2010,
Pubmed Schermuly,
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation.
2001,
Pubmed Schuliga,
The plasminogen activation system: new targets in lung inflammation and remodeling.
2013,
Pubmed Šedý,
Mechanisms of neurogenic pulmonary edema development.
2008,
Pubmed Sheng,
Functional role of extracellular loop cysteine residues of the epithelial Na+ channel in Na+ self-inhibition.
2007,
Pubmed
,
Xenbase Sheng,
Extracellular Zn2+ activates epithelial Na+ channels by eliminating Na+ self-inhibition.
2004,
Pubmed
,
Xenbase Sherwood,
Structure and activity of the acid-sensing ion channels.
2012,
Pubmed Shetty,
The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.
2008,
Pubmed Sisson,
Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice.
2002,
Pubmed Sisson,
The plasminogen activation system in lung disease.
2007,
Pubmed Stewart,
Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
2000,
Pubmed Strange,
Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.
1995,
Pubmed Stringer,
Tissue plasminogen activator (tPA) inhibits interleukin-1 induced acute lung leak.
1998,
Pubmed Stringer,
Administration of exogenous tissue plasminogen activator reduces oedema in mice lacking the tissue plasminogen activator gene.
2004,
Pubmed Takahashi,
Lung capillary endothelial cells produce and secrete urokinase-type plasminogen activator.
1992,
Pubmed Verspurten,
SitePredicting the cleavage of proteinase substrates.
2009,
Pubmed Viscardi,
Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
1992,
Pubmed Ware,
Clinical practice. Acute pulmonary edema.
2005,
Pubmed Ware,
Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury.
2006,
Pubmed Zeslawska,
Crystals of urokinase type plasminogen activator complexes reveal the binding mode of peptidomimetic inhibitors.
2003,
Pubmed
